But HCT know ASIC are watching over their shoulder. They are officially still under investigation, unless I missed the announcement that ASIC have concluded their investigation? They'd be stupid to be pulling tricks right under ASIC's nose. The trading halt request states, "further information" as opposed to, "clarification" which is the wording used in previous please explain related trading halts. HCT's release would also have to be cleared by the other company as they'll need assurance the statements are consistent with their contract. Last time their shares were suspended from official quotation they announced the 8M strategic partnership and then the launch of a list N product (Bioeque). In any case, we can focus on our other shares until Thursday at least.
HCT Price at posting:
5.2¢ Sentiment: Hold Disclosure: Held
